Since studies have shown that expression of visfatin increases in acute and chronic inflammatory conditions such as rheumatoid arthritis,11 acute pulmonary injury,13 and type II diabetes mellitus,15 a decrease in visfatin levels due to periodontal treatment might result in a decrease in the risk of diseases related to this factor. This evidence concerns the gene NAMPT and type 2 diabetes mellitus.